Skip to main content
Equibles

Kynam Capital Management, LP

Position in CADL — Candel Therapeutics, Inc.

CIK 1907884 PRINCETON, NJ
Back to CADL Full portfolio

Position in CADL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$996,432
+$16,432 QoQ
Shares Held
96,741
-51.6% QoQ
Ownership
0.126%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#35
of 138 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CADL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Kynam Capital Management, LP holds $1,765,169,848 across 29 Biotechnology names. CADL ranks #27 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 CLDX
Celldex Therapeutics, Inc.
 5,322,908 $198,065,406
2 SNDX
Syndax Pharmaceuticals Inc
 8,050,959 $175,993,963
3 PCVX
Vaxcyte, Inc.
 2,922,335 $169,875,333
4 COGT
Cogent Biosciences, Inc.
 3,667,097 $141,916,653
5 VERA
Vera Therapeutics, Inc.
 2,890,059 $124,012,431
6 VRDN
Viridian Therapeutics, Inc.\DE
 6,453,877 $118,557,720
7 TVTX
Travere Therapeutics, Inc.
 2,000,000 $113,620,000
8 BEAM
Beam Therapeutics Inc.
 2,840,792 $97,495,981

All Filings in CADL

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $996,432 96,741
2026-03-31 $980,000 200,000